Sonnet BioTherapeutics is no longer just a cancer drug developer. Its $888 million merger will place it among the largest HYPE holders, blurring the lines between traditional finance and decentralized protocols in a high-stakes treasury experiment. According to a July…
Related Posts
Bittensor price at risk as Root Reborn debate rattles TAO bulls
Bittensor’s TAO token has fallen nearly 20% from its June 15 peak after governance concerns, derivatives liquidations, and…
Early investors book NuggetRush as profit prospects surge; Jupiter, SUI, struggle
NuggetRush (NUGX), a new GameFi project, is attracting players and investors#partnercontent
Bitcoin price shrugs Germany’s $362m exchange deposit
Bitcoin’s market stabilized as Germany’s government shredded its BTC holdings from over 50,000 coins to under 23,000 tokens.